CD15 Antigens
150
relevant articles (1 outcomes,
12 trials/studies)
found for this Bio-Agent
Description:
Carbohydrate antigen which is accumulated in various human cancer tissues and secreted into the blood stream. The carbohydrate moiety can be further modified with fucose or sialic acid. Monoclonal antibodies have been determined which can discriminate each subgroup of this antigen in the sera of cancer patients. Sialyl SSEA-1 antigen is particularly elevated in the sera of patients with a variety of tumors.
Also Known As:
Antigens, CD15; 3-Fucosyl-N-acetyl-lactosamine; 3-Fucosyllactosamine Determinant; CD15 Antigen; Hapten X; Hapten Y; Lewis X Hapten; SSEA 1; SSEA 1 Determinant; 1 Determinant, SSEA; 3 Fucosyl N acetyl lactosamine; 3 Fucosyllactosamine Determinant; Determinant, SSEA 1; Embryonic Antigen-1, Stage-Specific; Fucosyl SSEA 1; Leu M1 Antigens; SSEA-1, Fucosyl; SSEA-1, Sialyl; Sialyl SSEA 1; Stage Specific Embryonic Antigen 1; Fucosyl SSEA-1; Le(X) Antigen; Leu-M1 Antigens; Lewis X Antigen; SSEA-1; SSEA-1 Determinant; Sialyl SSEA-1; Stage-Specific Embryonic Antigen-1
Relationship Network
Bio-Agent Context: Research Results